Revolving door, industry to regulators and back

Pandemic deputy chief medical officer moves to Moderna

Sir Jonathan Van-Tam
https://www.msn.com/en-gb/health/other/covid-guru-jonathan-van-tam-lands-senior-role-at-vaccine-maker-moderna/ar-AA1frazv

https://www.theguardian.com/business/2023/aug/18/former-covid-medical-officer-van-tam-takes-role-at-vaccine-maker-moderna

https://www.linkedin.com/posts/modernatx_moderna-is-delighted-to-announce-that-professor-activity-7059151698870579200-jF22/

UK former deputy chief medical officer

Senior Strategy Adviser in Medicine (Nottingham University)

Now (as of 2nd May) a senior medical consultant to the Covid-19 vaccine maker Moderna.

Was a member of the government vaccine taskforce during pandemic,

Made decisions on 'all vaccine supply contracts and major investments in manufacturing and clinical opportunities'.

https://www.youtube.com/watch?v=NJM9k1kq6ko

https://www.youtube.com/watch?v=kb7oMMYx0Yc

UK government

Britain bought 77,000,000 moderna vaccines

Struck a 10-year £billion partnership with Modern to build a new factory

https://www.theguardian.com/business/2022/jun/22/moderna-build-uk-mrna-vaccine-research-manufacturing-centre-covid

Government has committed to buying Moderna’s vaccines for the next decade.

JVT ‘advisory fee’, not disclosed

Prohibited from using privileged information from his time in government to further his business interests

Rose Whiffen, Transparency International UK

'Currently, there are only threadbare safeguards against abuse of the revolving door between the public and private sector.'

Created a 'risk of privileged information being misused for commercial benefit'.
https://www.gov.uk/government/people/patrick-vallance

Government Chief Scientific Adviser, April 2018 to April 2023

President, R&D at GlaxoSmithKline, 2012 to 2017

Had been Senior Vice President, Medicines Discovery and Development

(joined the company in May 2006 as Head of Drug Discovery)

He was a member of the GSK Board and the Corporate Executive Team.

https://www.theguardian.com/uk-news/2021/mar/19/patrick-vallance-adviser-scientific-truth-to-power

https://www.gsk.com/media/5346/remuneration-report.pdf